NuvOx Therapeutics
PrivateLast Round
Grant
Sep 26, 2025
Total Funding Raised
$20.69M
Company Overview
NuvOx Therapeutics is a clinical-stage biopharmaceutical company developing a first-in-class oxygen therapeutic designed to reverse tissue hypoxia in life-threatening diseases such as cancer, stroke, and respiratory distress.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NuvOx Therapeutics Comps
Public and private peers based on sector, stage, and business model.
NuvOx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 26, 2025 | ||||
| Convertible Debt | Sep 18, 2023 | ||||
| Grant | Feb 11, 2022 | ||||
| Grant | Apr 12, 2017 | ||||
| Grant | Oct 17, 2014 |
Key People
Founding team and executive leadership
NuvOx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Gulf South Angels | Convertible Debt |
| VisionTech Partners | Convertible Debt |
| U.S. Department of War | Grant |
| MEDA Angels | Convertible Debt |
| National Heart, Lung, and Blood Institute | Grant |
| New World Angels | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 26, 2025
$2M grant from the National Cancer Institute
- Jul 23, 2025
Grew 30% QoQ, from 10 to 13 employees.
NuvOx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NuvOx Therapeutics's valuation, stock price, and market status.
